2008
DOI: 10.1534/genetics.108.090936
|View full text |Cite
|
Sign up to set email alerts
|

Gene Dosage and Gene Duplicability

Abstract: The evolutionary process leading to the fixation of newly duplicated genes is not well understood. It was recently proposed that the fixation of duplicate genes is frequently driven by positive selection for increased gene dosage (i.e., the gene dosage hypothesis), because haploinsufficient genes were reported to have more paralogs than haplosufficient genes in the human genome. However, the previous analysis incorrectly assumed that the presence of dominant abnormal alleles of a human gene means that the gene… Show more

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
1
1
1

Citation Types

3
69
0

Year Published

2010
2010
2016
2016

Publication Types

Select...
6
2
1

Relationship

1
8

Authors

Journals

citations
Cited by 77 publications
(72 citation statements)
references
References 39 publications
(47 reference statements)
3
69
0
Order By: Relevance
“…This suggests that haploinsufficiency for either Pcbp1 or Pcbp2 is partially compensated for by wild-type levels of the sister isoform. As Pcbp1 and Pcbp2 have similar ribonucleotide binding specificities and operate through direct interactions with target RNAs and RNA processing machinery core components (22,25), we speculate that these findings are explained by a gene dose or dosage balance effect in pathways where Pcbp1 and Pcbp2 have overlapping functions (35,62,78). Thus, our data support a weight attenuation phenotype for Pcbp1-and Pcbp2-haploinsufficient and compound haploinsufficient mice, but at present the underlying specificity for this postnatal growth defect remains undetermined.…”
Section: Fig 7 Transcriptome Analysis Of Pcbp2supporting
confidence: 55%
“…This suggests that haploinsufficiency for either Pcbp1 or Pcbp2 is partially compensated for by wild-type levels of the sister isoform. As Pcbp1 and Pcbp2 have similar ribonucleotide binding specificities and operate through direct interactions with target RNAs and RNA processing machinery core components (22,25), we speculate that these findings are explained by a gene dose or dosage balance effect in pathways where Pcbp1 and Pcbp2 have overlapping functions (35,62,78). Thus, our data support a weight attenuation phenotype for Pcbp1-and Pcbp2-haploinsufficient and compound haploinsufficient mice, but at present the underlying specificity for this postnatal growth defect remains undetermined.…”
Section: Fig 7 Transcriptome Analysis Of Pcbp2supporting
confidence: 55%
“…Genes that require dosage balance tend not to duplicate successfully via individual gene duplication (IGD), but can be duplicated via WGD, because only the latter does not disrupt dosage balance. Given these considerations, one may predict that duplicates generated from WGD have a different adaptation pattern from duplicates generated from IGD (Papp et al 2003;Wapinski et al 2007;Qian and Zhang 2008). We compared the gains of fitness contribution from duplicates generated by WGD and those generated by IGD.…”
Section: Similar Adaptation Patterns From Different Modes Of Duplicationmentioning
confidence: 99%
“…The existence of conserved paralogous genes could be beneficial in increasing gene dosage (29 -32), maintaining the dosage balance of expressed proteins involved in multi-protein complexes and in regulatory networks of signal transduction and transcription (33)(34)(35)(36), and buffering against deleterious mutations in either one of the duplicate genes (37)(38)(39). Similar expression levels between the two yeast clades irrespective of gene duplication is inconsistent with the first theory, holding that an increase in gene dosage could be advantageous and therefore promote the fixation of duplicate genes.…”
Section: Discussionmentioning
confidence: 99%
“…Duplicate gene pairs in the minor group that are characterized by conserved sequences and slow evolution rates (21,26) and include genes encoding many cytoplasmic ribosomal proteins. The evolutionary role and mechanism of retention of duplicate genes with conserved sequences-that is, increasing protein abundance (gene dosage) (29 -32), dosage balance within protein complexes and regulatory networks (33)(34)(35)(36), and amelioration of risks arising from harmful mutations in either duplicate gene (37)(38)(39) -remain controversial (40 -42). Comparative analyses of protein abundance across yeast species are expected to provide insights into whether the presence of conserved duplicate genes confers an evolutionary advantage with respect to protein dosage.…”
mentioning
confidence: 99%